Prioritizing causal genes at type 2 diabetes risk loci by Grotz, A, Gloyn, A, Thomsen, S

A CRISPR/Cas9 genome editing pipeline in the EndoC-βH1 cell line to study genes implicated in beta cell function by Grotz, A, Abaitua, F, Navarro-Guerrero, E, Hastoy, B, Ebner, D, Gloyn, A

Loss of ZnT8 function protects against diabetes by enhanced insulin secretion by Dwivedi, O, Lehtovirta, M, Hastoy, B, Chandra, V, Krentz, N, Kleiner, S, Jain, D, Richard, A, Abaitua, F, Beer, N, Grotz, A, Prasad, R, Hansson, O, Ahlqvist, E, Krus, U, Artner, I, Suoranta, A, Gomez, D, Baras, A, Champon, B, Payne, A, Moralli, D, Thomsen, S, Kramer, P, Spiliotis, I, Ramracheya, R, Chabosseau, P, Theodoulou, A, Cheung, R, Van De Bunt, M, Flannick, J, Trombetta, M, Bonora, E, Wolheim, C, Sarelin, L, Bonadonna, R, Rorsman, P, Davies, B, Brosnan, J, McCarthy, M, Otonkoski, T, Lagerstedt, J, Rutter, G, Gromada, J, Gloyn, A, Tuomi, T, Groop, L